volume 97 pages 103470

Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line

Publication typeJournal Article
Publication date2020-04-01
scimago Q1
wos Q1
SJR0.786
CiteScore8.3
Impact factor4.7
ISSN00452068, 10902120
Organic Chemistry
Drug Discovery
Biochemistry
Molecular Biology
Abstract
Pyrazole is a five-membered aromatic heterocyclic ring with two adjacent nitrogen atoms C3H3N2H.The presence of this nucleus in pharmacological agents of various therapeutic categories gifts a broad spectrum of biological activities and pharmaceuticals that contain pyrazole like celecoxib (anti-inflammatory), CDPPB (antipsychotic), Rimonabant (anti-obesity), Difenamizole, (Analgesic), Betazole (H2 receptor agonist), Fezolamide (Antidepressant), etc… The pharmacological potential of the pyrazole fraction is proved in many publication where they synthesized and evaluated pyrazoles against several biological agents. The aim of this article review is to survey recent works linking pyrazole structures to anticancer activities corresponding to 9 different type of cancer.
Found 
Found 

Top-30

Journals

5
10
15
20
25
30
35
Journal of Molecular Structure
31 publications, 11.44%
ChemistrySelect
19 publications, 7.01%
Molecules
13 publications, 4.8%
Journal of Organic Chemistry
8 publications, 2.95%
International Journal of Molecular Sciences
8 publications, 2.95%
Chemistry and Biodiversity
7 publications, 2.58%
ACS Omega
6 publications, 2.21%
Future Medicinal Chemistry
5 publications, 1.85%
Bioorganic Chemistry
5 publications, 1.85%
Russian Journal of Organic Chemistry
5 publications, 1.85%
Chemical Data Collections
4 publications, 1.48%
Archiv der Pharmazie
4 publications, 1.48%
Journal of Agricultural and Food Chemistry
4 publications, 1.48%
Molecular Diversity
4 publications, 1.48%
Scientific Reports
4 publications, 1.48%
Bioorganic and Medicinal Chemistry Letters
4 publications, 1.48%
Medicinal Chemistry
3 publications, 1.11%
Pharmaceuticals
3 publications, 1.11%
Monatshefte fur Chemie
3 publications, 1.11%
European Journal of Medicinal Chemistry
3 publications, 1.11%
Journal of Heterocyclic Chemistry
3 publications, 1.11%
Asian Journal of Organic Chemistry
3 publications, 1.11%
New Journal of Chemistry
3 publications, 1.11%
RSC Advances
3 publications, 1.11%
Journal of Biomolecular Structure and Dynamics
3 publications, 1.11%
Polycyclic Aromatic Compounds
3 publications, 1.11%
AIP Conference Proceedings
3 publications, 1.11%
Current Organic Synthesis
3 publications, 1.11%
Mini-Reviews in Medicinal Chemistry
2 publications, 0.74%
Pharmaceutics
2 publications, 0.74%
5
10
15
20
25
30
35

Publishers

10
20
30
40
50
60
70
80
Elsevier
73 publications, 26.94%
Wiley
42 publications, 15.5%
MDPI
36 publications, 13.28%
Springer Nature
25 publications, 9.23%
American Chemical Society (ACS)
23 publications, 8.49%
Taylor & Francis
18 publications, 6.64%
Bentham Science Publishers Ltd.
12 publications, 4.43%
Royal Society of Chemistry (RSC)
11 publications, 4.06%
Pleiades Publishing
7 publications, 2.58%
Walter de Gruyter
3 publications, 1.11%
AIP Publishing
3 publications, 1.11%
Shanghai Institute of Organic Chemistry
2 publications, 0.74%
Frontiers Media S.A.
2 publications, 0.74%
Hindawi Limited
2 publications, 0.74%
International Union of Crystallography (IUCr)
2 publications, 0.74%
Georg Thieme Verlag KG
2 publications, 0.74%
King Saud University
1 publication, 0.37%
Asian Journal of Chemistry
1 publication, 0.37%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 0.37%
Akademizdatcenter Nauka
1 publication, 0.37%
A and V Publications
1 publication, 0.37%
Lviv Polytechnic National University
1 publication, 0.37%
10
20
30
40
50
60
70
80
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
272
Share
Cite this
GOST |
Cite this
GOST Copy
Bennani F. E. et al. Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line // Bioorganic Chemistry. 2020. Vol. 97. p. 103470.
GOST all authors (up to 50) Copy
Bennani F. E., Doudach L., Cherrah Y., Ramli Y., Karrouchi K., Ansar M., Faouzi M. E. A. Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line // Bioorganic Chemistry. 2020. Vol. 97. p. 103470.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.bioorg.2019.103470
UR - https://doi.org/10.1016/j.bioorg.2019.103470
TI - Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line
T2 - Bioorganic Chemistry
AU - Bennani, Fatima Ezzahra
AU - Doudach, Latifa
AU - Cherrah, Y.
AU - Ramli, Youssef
AU - Karrouchi, Khalid
AU - Ansar, M'hammed
AU - Faouzi, My El Abbes
PY - 2020
DA - 2020/04/01
PB - Elsevier
SP - 103470
VL - 97
PMID - 32120072
SN - 0045-2068
SN - 1090-2120
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2020_Bennani,
author = {Fatima Ezzahra Bennani and Latifa Doudach and Y. Cherrah and Youssef Ramli and Khalid Karrouchi and M'hammed Ansar and My El Abbes Faouzi},
title = {Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line},
journal = {Bioorganic Chemistry},
year = {2020},
volume = {97},
publisher = {Elsevier},
month = {apr},
url = {https://doi.org/10.1016/j.bioorg.2019.103470},
pages = {103470},
doi = {10.1016/j.bioorg.2019.103470}
}